Skip to main content

Table 1 Absolute and mean relative error for the determination of the EOA in the in vitro study

From: Cardiovascular magnetic resonance evaluation of aortic stenosis severity using single plane measurement of effective orifice area

Effective Orifice area (cm2)

Method

Absolute error (cm2)

Mean relative error (%)

0.48

CMRCONT

0.10 ± 0.02

23 ± 5

 

CMRJSLD

0.02 ± 0.01

4 ± 3

 

CMRSPVT

0.02 ± 0.004

5 ± 1

1.00

CMRCONT

0.03 ± 0.01

3 ± 1

 

CMRJSLD

0.04 ± 0.04

4 ± 4

 

CMRSPVT

0.05 ± 0.02

5 ± 2

1.38

CMRCONT

0.09 ± 0.02

6 ± 2

 

CMRJSLD

0.04 ± 0.03

3 ± 2

 

CMRSPVT

0.04 ± 0.02

3 ± 1

2.11

CMRCONT

0.06 ± 0.03

3 ± 2

 

CMRJSLD

0.03 ± 0.03

1 ± 1

 

CMRSPVT

0.08 ± 0.07

4 ± 3

All orifices

CMRCONT

0.07 ± 0.04

9 ± 9

 

CMRJSLD

0.03 ± 0.03

3 ± 3

 

CMRSPVT

0.05 ± 0.04

4 ± 2

  1. The reference value is the EOA predicted using potential flow theory (EOA = Cc × GOA), where GOA is the geometrical orifice area and Cc is the contraction coefficient that is = 0.61 (i.e. value for Cc for harp-edge orifices with small aspect ratio). CMRCONT: EOA determined using continuity equation; CMRJSLD: EOA determined using shear layer detection (JSLD) based on acoustical source term concept; CMRSPVT: EOA determined using single plane velocity truncation (SPVT) method.